Medication info
Plavix Tablets (Clopidogrel Sulfate)

Plavix Tablets (Clopidogrel Sulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Korea Prime Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201200603 · Notified 2012.01.27 · Insurance code 663605510

Summary

Main use
Improvement of atherosclerotic symptoms, improvement of symptoms of acute coronary syndrome, and prevention of thrombi in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg once daily orally. Aspirin 75 ~ 325 mg should be administered concomitantly with this drug once daily. 3. For patients with atrial fibrillation, administer this drug 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this drug once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate hepatic disease and a bleeding diathesis is limited. This drug may be administered with or without food.

Ingredients

Manufacturer
Korea Prime Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of atherosclerotic symptoms, improvement of symptoms of acute coronary syndrome, and prevention of thrombi in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • non-Q wave myocardial infarction
  • cardiovascular anomalies
  • stroke
  • persistent ischemia
  • vascular risk factors
  • bleeding risk
  • atrial fibrillation
View approved original text

This medication is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. It also alleviates symptoms such as cardiovascular-related mortality, myocardial infarction, stroke, or persistent ischemia in patients with acute coronary syndrome who have undergone medical treatment, coronary intervention procedures, or coronary artery bypass surgery. Furthermore, it assists in reducing the risk of stroke and thromboembolism in patients with atrial fibrillation when vitamin K antagonists are unsuitable and bleeding risk is low. This medication is effective in lowering the risk of various cardiovascular diseases and improving symptoms.

How to take

Adult dose

○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg once daily orally. Aspirin 75 ~ 325 mg should be administered concomitantly with this drug once daily. 3. For patients with atrial fibrillation, administer this drug 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this drug once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate hepatic disease and a bleeding diathesis is limited. This drug may be administered with or without food.

Precautions

This medication helps blood flow by preventing platelets in the blood from clumping together. It may not be effective enough in individuals with reduced function of a specific enzyme (CYP2C19) due to genetic factors. In such cases, alternative treatments should be considered. Additionally, concomitant use of medications that activate certain enzymes may increase the risk of bleeding, so such combinations should be avoided. This medication should not be used in patients with bleeding, severe liver damage, breastfeeding women, or those with specific genetic disorders. During administration, there is a risk of bleeding, so if bleeding symptoms are suspected, medical personnel should be informed immediately. The use of this medication may need to be stopped in case of surgery or trauma. Caution is warranted if this medication is used alongside anticoagulants such as warfarin, as this increases the risk of bleeding. Moreover, it may cause side effects like gastrointestinal bleeding, skin rashes, and a reduction in blood cell counts, so if any unusual symptoms occur, consultation with a doctor should be sought immediately. While the risk to the fetus during pregnancy is not significant, caution is needed due to the bleeding risk, and consideration should be given to whether to discontinue breastfeeding since the medication may pass into breast milk. This medication is not recommended for children as safety and efficacy have not been established. For elderly patients or those with impaired kidney or liver function, there may be a higher risk of bleeding, thus dosage adjustment and careful monitoring are necessary. In case of overdose, the risk of bleeding significantly increases, requiring immediate hospital care for appropriate treatment. This medication should be stored out of reach of children and not transferred to another container for safety.

Side effects

  • Hemorrhage
  • gastrointestinal bleeding
  • bleeding requiring hospitalization
  • purpura
  • contusion
  • hematoma
  • epistaxis
  • hematoma
  • hematuria
  • intraocular hemorrhage
Show 150 more
  • intracranial hemorrhage
  • major bleeding
  • minor bleeding
  • hemorrhagic stroke
  • thrombocytopenia
  • neutropenia
  • aplastic anemia
  • abdominal pain
  • dyspepsia
  • diarrhea
  • rash
  • pruritus
  • chest pain
  • accidental injury
  • influenza-like illness
  • pain
  • fatigue
  • edema
  • hypertension
  • headache
  • dizziness
  • nausea
  • depression
  • upper respiratory tract infection
  • dyspnea
  • rhinitis
  • bronchitis
  • cough
  • urinary tract infection
  • fainting
  • palpitations
  • asthenia
  • fever
  • hernia
  • heart failure
  • atrial fibrillation
  • leg cramps
  • sensory disturbance
  • neuralgia
  • sensory abnormalities
  • vertigo
  • constipation
  • vomiting
  • increased liver enzymes
  • gout
  • hyperuricemia
  • arthritis
  • arthrosis
  • anxiety
  • insomnia
  • anemia
  • pneumonia
  • sinusitis
  • eczema
  • skin ulcer
  • cystitis
  • cataract
  • conjunctivitis
  • decreased motor function
  • tremor
  • voice disorder
  • abnormal gait
  • hyperkinesia
  • ataxia
  • perceptual disturbance
  • insomnia
  • depression
  • amnesia
  • anxiety
  • confusion
  • abnormal thoughts
  • abnormal behavior
  • arthralgia
  • myalgia
  • lower back pain
  • gynecomastia
  • elevated prostate-specific antigen
  • cholecystitis
  • hematemesis
  • spinal hematoma
  • vasculitis
  • hypotension
  • bronchospasm
  • interstitial pneumonia
  • eosinophilic pneumonia
  • colitis
  • pancreatitis
  • gastritis
  • stomatitis
  • hepatitis
  • acute liver failure
  • shingles
  • erythematous rash
  • maculopapular rash
  • urticaria
  • angioedema
  • vesicular dermatitis
  • drug-induced hypersensitivity syndrome
  • eosinophilia
  • drug rash
  • lichen planus
  • glomerulonephritis
  • fever
  • abnormal liver function tests
  • increased serum creatinine
  • allergic symptoms
  • ischemic necrosis
  • hemorrhagic arthropathy
  • hematuria
  • hemoptysis
  • retroperitoneal bleeding
  • pulmonary hemorrhage
  • purpura
  • melena
  • gingival bleeding
  • leukemia
  • leukopenia
  • eosinophilia
  • menorrhagia
  • hemothorax
  • renal dysfunction
  • acute renal failure
  • Kounis syndrome
  • anaphylactoid reaction
  • serum sickness
  • confusion
  • hallucinations
  • taste disturbance
  • loss of taste
  • vasculitis
  • hypotension
  • bronchospasm
  • interstitial pneumonia
  • eosinophilic pneumonia
  • colitis
  • pancreatitis
  • gastritis
  • stomatitis
  • hepatitis
  • acute liver failure
  • shingles
  • erythematous rash
  • maculopapular rash
  • urticaria
  • angioedema
  • vesicular dermatitis
  • drug-induced hypersensitivity syndrome
  • eosinophilia
  • drug rash
  • lichen planus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is best to maintain a storage temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.